69 related articles for article (PubMed ID: 10490695)
1. No association between DFNA6 and Pro250Arg mutation in FGFR3.
Bespalova IN; Burmeister M; Lesperance MM
Am J Med Genet; 1999 Oct; 88(5):451. PubMed ID: 10490695
[No Abstract] [Full Text] [Related]
2. Familial craniosynostosis due to Pro250Arg mutation in the fibroblast growth factor receptor 3 gene.
Hughes J; Nevin NC; Morrison PJ
Ulster Med J; 2001 May; 70(1):47-50. PubMed ID: 11428324
[No Abstract] [Full Text] [Related]
3. Deafness due to Pro250Arg mutation of FGFR3.
Hollway GE; Suthers GK; Battese KM; Turner AM; David DJ; Mulley JC
Lancet; 1998 Mar; 351(9106):877-8. PubMed ID: 9525367
[No Abstract] [Full Text] [Related]
4. The genetic basis of dwarfism.
Francomano CA
N Engl J Med; 1995 Jan; 332(1):58-9. PubMed ID: 7990869
[No Abstract] [Full Text] [Related]
5. Confirmatory linkage of hypochondroplasia to chromosome arm 4p.
Hecht JT; Herrera CA; Greenhaw GA; Francomano CA; Bellus GA; Blanton SH
Am J Med Genet; 1995 Jul; 57(3):505-6. PubMed ID: 7677163
[No Abstract] [Full Text] [Related]
6. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14).
Intini D; Baldini L; Lombardi L; Neri A
Leukemia; 2002 Jun; 16(6):1201-2. PubMed ID: 12040455
[No Abstract] [Full Text] [Related]
8. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.
Tsai FJ; Tsai CH; Chang JG; Wu JY
Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885
[No Abstract] [Full Text] [Related]
9. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
Ronchetti D; Greco A; Compasso S; Colombo G; Dell'Era P; Otsuki T; Lombardi L; Neri A
Oncogene; 2001 Jun; 20(27):3553-62. PubMed ID: 11429702
[TBL] [Abstract][Full Text] [Related]
10. Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3.
Van Esch H; Fryns JE
Genet Couns; 2004; 15(3):375-7. PubMed ID: 15517832
[No Abstract] [Full Text] [Related]
11. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
Cappellen D; De Oliveira C; Ricol D; de Medina S; Bourdin J; Sastre-Garau X; Chopin D; Thiery JP; Radvanyi F
Nat Genet; 1999 Sep; 23(1):18-20. PubMed ID: 10471491
[No Abstract] [Full Text] [Related]
12. Clinical spectrum of fibroblast growth factor receptor mutations.
Passos-Bueno MR; Wilcox WR; Jabs EW; Sertié AL; Alonso LG; Kitoh H
Hum Mutat; 1999; 14(2):115-25. PubMed ID: 10425034
[TBL] [Abstract][Full Text] [Related]
13. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.
Sibley K; Cuthbert-Heavens D; Knowles MA
Oncogene; 2001 Feb; 20(6):686-91. PubMed ID: 11314002
[TBL] [Abstract][Full Text] [Related]
15. Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.
Pokharel RK; Alimsardjono H; Takeshima Y; Nakamura H; Naritomi K; Hirose S; Onishi S; Matsuo M
Biochem Biophys Res Commun; 1996 Oct; 227(1):236-9. PubMed ID: 8858131
[TBL] [Abstract][Full Text] [Related]
16. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
17. Partial craniosynostosis in a patient with deletion 22q11.
Karteszi J; Kress W; Szasz M; Czako M; Melegh B; Kosztolanyi GY; Morava E
Genet Couns; 2004; 15(4):481-3. PubMed ID: 15658627
[No Abstract] [Full Text] [Related]
18. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
19. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
[TBL] [Abstract][Full Text] [Related]
20. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.
Muenke M; Gripp KW; McDonald-McGinn DM; Gaudenz K; Whitaker LA; Bartlett SP; Markowitz RI; Robin NH; Nwokoro N; Mulvihill JJ; Losken HW; Mulliken JB; Guttmacher AE; Wilroy RS; Clarke LA; Hollway G; Adès LC; Haan EA; Mulley JC; Cohen MM; Bellus GA; Francomano CA; Moloney DM; Wall SA; Wilkie AO
Am J Hum Genet; 1997 Mar; 60(3):555-64. PubMed ID: 9042914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
